Literature DB >> 25905901

Rutaecarpine analogues reduce lipid accumulation in adipocytes via inhibiting adipogenesis/lipogenesis with AMPK activation and UPR suppression.

Ying-Chun Chen, Xiao-Yi Zeng, Yan He, Hong Liu, Bin Wang, Han Zhou, Jian-Wen Chen, Pei-Qing Liu, Lian-Quan Gu, Ji-Ming Ye, Zhi-Shu Huang.   

Abstract

Entities:  

Year:  2015        PMID： 25905901     DOI： 10.1021/acschembio.5b00242

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN： 1554-8929            Impact factor:   5.100


× No keyword cloud information.
  3 in total

1.  Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity.

Authors:  Yong Rao; Yu-Ting Lu; Chan Li; Qin-Qin Song; Yao-Hao Xu; Zhao Xu; Yu-Tao Hu; Hong Yu; Lin Gao; Lian-Quan Gu; Ji-Ming Ye; Zhi-Shu Huang
Journal:  Br J Pharmacol       Date:  2019-07-04       Impact factor: 8.739

2.  Natural alkaloid bouchardatine ameliorates metabolic disorders in high-fat diet-fed mice by stimulating the sirtuin 1/liver kinase B-1/AMPK axis.

Authors:  Yong Rao; Hong Yu; Lin Gao; Yu-Ting Lu; Zhao Xu; Hong Liu; Lian-Quan Gu; Ji-Ming Ye; Zhi-Shu Huang
Journal:  Br J Pharmacol       Date:  2017-06-21       Impact factor: 8.739

3.  Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy.

Authors:  Yuning Liao; Yuan Liu; Xiaohong Xia; Zhenlong Shao; Chuyi Huang; Jinchan He; Lili Jiang; Daolin Tang; Jinbao Liu; Hongbiao Huang
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.